Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Amgen Inc

02 2F. Hoffmann-La Roche

03 2Pfizer Inc

04 2Spirig Healthcare

05 2Teva Pharmaceutical Industries

06 2iQone Healthcare Switzerland SA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Bevacizumabum

Brand Name : Mvasi

Dosage Form : Inf Conc

Dosage Strength : 100mg/4ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

02

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Bevacizumabum

Brand Name : Mvasi

Dosage Form : Inf Conc

Dosage Strength : 400mg/16ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Bevacizumabum

Brand Name : Avastin

Dosage Form : Inf Konz

Dosage Strength : 100mg/4ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

04

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Bevacizumabum

Brand Name : Avastin

Dosage Form : Inf Konz

Dosage Strength : 400mg/16ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

05

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Bevacizumabum

Brand Name : Zirabev

Dosage Form : Inf Conc

Dosage Strength : 100mg/4ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

06

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Bevacizumabum

Brand Name : Zirabev

Dosage Form : Inf Conc

Dosage Strength : 400mg/16ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

07

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Bevacizumabum

Brand Name : Oyavas

Dosage Form : Inf Conc

Dosage Strength : 100mg/4ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

08

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Bevacizumabum

Brand Name : Oyavas

Dosage Form : Inf Conc

Dosage Strength : 400mg/16ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

09

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Bevacizumabum

Brand Name : Bevacizumab-Teva

Dosage Form : Inf Konz

Dosage Strength : 100mg/4ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

10

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

Bevacizumabum

Brand Name : Bevacizumab-Teva

Dosage Form : Inf Conc

Dosage Strength : 400mg/16ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

11

iQone Healthcare Switzerland SA

Country
Fi Europe 2024
Not Confirmed
arrow

iQone Healthcare Switzerland SA

Country
arrow
Fi Europe 2024
Not Confirmed

Bevacizumabum

Brand Name : Vegzelma

Dosage Form : Inf Conc

Dosage Strength : 100mg/4ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

12

iQone Healthcare Switzerland SA

Country
Fi Europe 2024
Not Confirmed
arrow

iQone Healthcare Switzerland SA

Country
arrow
Fi Europe 2024
Not Confirmed

Bevacizumabum

Brand Name : Vegzelma

Dosage Form : Inf Conc

Dosage Strength : 400mg/16ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank